BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 15656390)

  • 1. [The principles of action and use of phlebotropic agents].
    Kharkevich DA
    Klin Med (Mosk); 2004; 82(11):4-10. PubMed ID: 15656390
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinico-statistical study on the activity of a phlebo-active drug Fleboplex in obstetrical and gynecologic pathology].
    Ricci MG
    Minerva Ginecol; 1974 Nov; 26(11):641-6. PubMed ID: 4444806
    [No Abstract]   [Full Text] [Related]  

  • 3. [The drug therapy of chronic venous insufficiency (a trial of the clinical use of the preparation Detralex)].
    Iablokov EG; Bogachev VIu; Domoradskaia AI
    Ter Arkh; 1996; 68(10):80-1. PubMed ID: 9026954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of the therapeutic effect of a phlebotropic drug with a new noninvasive method: rheography by reflected light].
    Tumino G; Berni A; Tromba L; Marignetti L
    Clin Ter; 1987 Aug; 122(3):189-94. PubMed ID: 2973911
    [No Abstract]   [Full Text] [Related]  

  • 5. Techniques used to evaluate the cutaneous microcirculation: application of photoplethysmography to the assessment of a phlebotropic agent in the treatment of leg ulcers.
    Guillot B
    Angiology; 1994 Jun; 45(6 Pt 2):542-8. PubMed ID: 8203785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. At the crossroads of venous insufficiency and hemorrhoidal disease: Daflon 500 mg--repercussions of venous insufficiency on everyday life.
    Launois R
    Angiology; 1994 Jun; 45(6 Pt 2):495-504. PubMed ID: 8203779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlled studies of Daflon 500 mg in chronic venous insufficiency.
    Geroulakos G; Nicolaides AN
    Angiology; 1994 Jun; 45(6 Pt 2):549-53. PubMed ID: 8203786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical experiences with a vasoprotective drug in the treatment of venous problems of the lower limbs].
    De Caprio M; Vinci L; Giumetti D; Colitta G
    Clin Ter; 1982 Jun; 101(5):497-508. PubMed ID: 6897029
    [No Abstract]   [Full Text] [Related]  

  • 9. [VARICOSE DISEASE OF THE LOWER EXTREMITIES: CAUSES, COMPLICATIONS, CHOICE OF METHODS FOR TREATMENT AND PROPHYLAXIS].
    Korzhyk NP
    Klin Khir; 2016 Feb; (2):52-5. PubMed ID: 27244921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flavonoids. A review of the pharmacology and therapeutic efficacy of Daflon 500 mg in patients with chronic venous insufficiency and related disorders.
    Struckmann JR; Nicolaides AN
    Angiology; 1994 Jun; 45(6):419-28. PubMed ID: 8203767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Conservative and surgical measures in phlebologic consulatation. Report on the potassium-neutral venous diuretic Dehydro-sanol-tri].
    Wissniowski T; Harlin-Wissniowski A
    Fortschr Med; 1974 Oct; 92(28):1132-7. PubMed ID: 4616896
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical evaluation of a new drug in phlebology].
    Spartera C; Santoro P; Frezzotti A; Marciani A; Ricci G
    Clin Ter; 1979 Jan; 88(2):139-47. PubMed ID: 428194
    [No Abstract]   [Full Text] [Related]  

  • 13. At the Crossroads of Venous Insufficiency and Hemorrhoidal Disease: Daflon 500 mg. Proceedings of a symposium. Vienna, Austria, January 31, 1992.
    Angiology; 1994 Jun; 45(6 Pt 2):493-584. PubMed ID: 7911285
    [No Abstract]   [Full Text] [Related]  

  • 14. [Evaluation of the efficacy of a phlebotropic drug by the Doppler method].
    Severin E; Mladovan G
    Minerva Cardioangiol; 1988; 36(7-8):375-6. PubMed ID: 3062488
    [No Abstract]   [Full Text] [Related]  

  • 15. [Monitoring the quality of life in patients with varicose disease of the lower extremities in the use of venarus].
    Stoĭko IuM; Gudymovich VG
    Khirurgiia (Mosk); 2010; (6):46-51. PubMed ID: 20919433
    [No Abstract]   [Full Text] [Related]  

  • 16. [Varicose vein drugs--new attempts at objectivation of the effects of therapy].
    Marshall M
    Fortschr Med; 1984 Aug; 102(29-30):772-4. PubMed ID: 6500447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advantage of a micronized flavonoidic fraction (Daflon 500 mg) in comparison with a nonmicronized diosmin.
    Amato C
    Angiology; 1994 Jun; 45(6 Pt 2):531-6. PubMed ID: 8203783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Edema as a measure for severity of chronic venous insufficiency and efficacy of its treatment].
    Sapelkin SV
    Angiol Sosud Khir; 2008; 14(3):79-81. PubMed ID: 19791434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diosmin-containing phlebotropic drugs in varicose eczema].
    Rodnyansky DV; Fokin AA
    Angiol Sosud Khir; 2019; 25(3):88-92. PubMed ID: 31503251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hemorrhoids and conservative treatment. Review of the literature on the use of diosmin and micronized hesperidin].
    La Torre F; Nicolai AP; Otti M
    Minerva Chir; 1999 Dec; 54(12):909-16. PubMed ID: 10736998
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.